EHRA Premium Access

Venous thrombosis in patients after catheter ablation.Efficacy and safety of enoxaparin therapy with the transition to warfarin and monotherapy with rivaroxaban

Congress Presentation

About the speaker

Miss Anastasia Loginova

Russian Cardiology Research and Production Complex, Moscow (Russian Federation)
0 follower

6 more presentations in this session

Comparison of the efficacy and safety of injectable propafenone and amiodarone for elimination of paroxysmal atrial fibrillation in patients without organic heart disease.

Speaker: Doctor A. Tarasov (Moscow, RU)


Effect of efficient lipid-lowering atorvastatin therapy on heart rate variability in the post-infarction period

Speaker: Professor V. Oleinikov (Penza, RU)


QT dispersion in patients with myocardial infarction and high-dose therapy with atorvastatin

Speaker: Professor V. Oleinikov (Penza, RU)


Antiarrhythmic relevance of inhibiting cardiac and non-cardiac sodium channel isoforms for the suppression of torsades de pointes arrhythmias in the chronic av block dog

Speaker: Mr A. Bossu (Utrecht, NL)


Analysis of predictive factors for propafenone proarrythmia. Does exercise ECG play a role during long term propafenone treatment?

Speaker: Mr P. Kalmar (Debrecen, HU)


Access the full session

Poster session 2 - Arrhythmias

Speakers: Miss A. Loginova, Doctor A. Tarasov, Professor V. Oleinikov, Professor V. Oleinikov, Mr A. Bossu...

About the event


EHRA 2019

17 March - 19 March 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb